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Background/aim: The aim of this study was to evaluate anesthesia management in cesarean operation of pregnant women who
underwent renal transplantation and the effects on postoperative renal function, retrospectively.
Materials and methods: After obtaining the approval of the ethics committee of our hospital, the records of pregnant women who
underwent kidney transplantation and cesarean section between 2007 and 2017 were retrospectively analyzed. The patients’ demographic
data, concomitant disease history, the treatment received, and type of anesthesia were retrospectively evaluated and recorded in the
follow-up form.
Results: It was found that a total of 47 women who underwent renal transplantation had 47 live births by cesarean section. The mean
age of the pregnant women was 30 ± 5.34 years. The mean time between renal transplantation and conception was 95.34 ± 55.02
months. It was found that 14 (29%) of a total of 47 patients had their first pregnancy. The number of patients with a gravidity of 4
and above was 9 (19%). A total of 21 (44.7%) pregnant women had spontaneous miscarriage. Five (10.6%) patients were treated with
curettage for therapeutic purposes. Twenty-two (46%) of the patients whose immunosuppressive therapy was continuing were treated
with azathioprine, tacrolimus, and prednisolone. The mean gestational age of delivery was 36.5 ± 1.59 weeks. The rate of prepregnancy
hypertension diagnosis was 25.5% (n = 12), while the rate of developing gestational hypertension was 21.3% (n = 10). Spinal anesthesia
was administered to 42 (91%) of 47 patients who underwent cesarean section. In the preoperative period, the mean value of serum blood
urea nitrogen was 62.88 ± 41.97 mg/dL and the mean serum creatinine level was 3.21 ± 6.17 mg/dL. In the postoperative period, these
values were 44.4 ± 29.9 mg/dL and 1.91 ± 1.63 mg/dL, respectively. When the pre- and postoperative serum urea and creatinine levels
were compared, they were found to be lower in the postoperative period. However, there was no statistically significant difference (P >
0.05). The mean weight of the newborns was determined as 2707.3 ± 501.5 g. While the number of newborns with a low birth weight
(<2500 g) was 18 (38%), among them 3 (0.6%) were below 2000 g. It was found that 36.2% (n = 17) of the newborns required intensive
care. None of the patients developed graft rejection.
Conclusion: If there is no contraindication, regional anesthesia may be preferred in the first place for pregnant women with renal
transplantation. We suggest that this method of anesthesia has some advantages in terms of maintaining postoperative renal function
and higher Apgar scores in newborns with low birth weight.
Key words: Obstetric anesthesia, renal transplantation, pregnancy

1. Introduction
Menstrual cycle disorders and amenorrhea are common
problems in women with chronic renal failure. The reason
is the suppression of gonadotropin-releasing hormone
(GnRH) secretion due to uremia, and hypothalamopituitary dysfunction. Especially with new and advanced
treatment protocols, the rate of conception is now 0.5%–
7% among patients with end stage renal failure. As a result
of the increase in the success rate of renal transplantations,
renal and endocrine functions are rapidly restored in these

patients and ovulatory cycles occur. Although a successful
conception is achieved after renal transplantation,
numerous maternal and fetal risks may arise. It is
important to keep the immunosuppressive drug doses
used after renal transplantation in pregnant women who
underwent renal transplantation at a proper level in terms
of both maintaining the graft function and protecting
the health of the mother and fetus. While the number of
abortions is quite high in these patient groups, prematurity
and intrauterine growth restriction (IUGR) commonly
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arise in ongoing pregnancies. The anesthetist also has an
important role in the management of these patients. With
the anesthetic and analgesic techniques to be selected,
drugs should not have harmful effects on the patient and
the newborn. The literature on anesthetic management
of pregnant patients with renal transplantation during
cesarean section is quite limited. In this study, we aimed to
evaluate and share our patients who underwent cesarean
section after renal transplantation in our hospital.
2. Materials and methods
After obtaining the approval of the ethics committee of our
hospital, the anesthesia and birth records of 47 pregnant
women with kidney transplantation who underwent
cesarean section in the Obstetrics and Gynecology Clinic
between 2007 and 2017 were analyzed retrospectively.
The patients’ demographic data, number and duration
of pregnancy, parity, gravity, spontaneous abortion,
concomitant disease history, immunosuppressive therapy
received, type of anesthesia, duration of anesthesia
and operative time, newborn weight, Apgar score, and
requirement of intensive care of the mother and the
newborn were evaluated retrospectively and recorded in
the follow-up form.
For statistical evaluation SPSS 12.0 (SPSS Inc., Chicago,
IL, USA) was used. The mean, standard deviation, median,
minimum, maximum, frequency, and ratio were used
in the definitive statistics of the study and P < 0.05 was
accepted as significant. The Wilcoxon test was used to
compare urea/creatinine values before and after cesarean
section.
3. Results
It was found that a total of 47 women who underwent renal
transplantation had 47 live births by cesarean section. The
mean age of the pregnant women was 30 ± 5.34 years. The
mean time between renal transplantation and conception
was 95.34 ± 55.02 months. The number of pregnant women
on contraception was 5. Twenty-two (46%) of the patients
whose immunosuppressive therapy was continuing were

treated with azathioprine, tacrolimus, and prednisolone.
The number of patients using cyclosporine, tacrolimus,
and prednisolone was 15 (31%). The remaining 10 (21%)
patients were using these drugs alone or in different
combinations (Table 1).
It was found that 14 (29%) of a total of 47 patients
had their first pregnancy. The number of patients with a
gravidity of 4 and above was 9 (19%). Maternal reasons
justified 41 (87.2%) patients undergoing cesarean sections.
The median gestational age was 36.5 weeks (min 33–max
39 weeks). It was found that the number of pregnant
women with a gestational age below 36 weeks was 10
(21%). Cesarean indications of these patients were due
to fetal distress only in 1 pregnant woman. A total of 21
(44.7%) pregnant women had spontaneous miscarriage.
Five (10.6%) patients were treated with curettage for
therapeutic purposes (Table 2). The rate of prepregnancy
hypertension diagnosis was 25.5% (n = 12), while the rate
of developing gestational hypertension was 21.3% (n =
10). The number of patients who developed preeclampsia
was 6 (12%) (Table 3). Gestational age of these pregnant
women was more than 36 weeks. Superimposed
preeclampsia was defined as having chronic hypertension
with a blood pressure of greater than 140/90 mmHg
and proteinuria above 300 mg/L after the 20th week of
gestation. None of our patients developed superimposed
preeclampsia. During the pregnancy, 4 (0.08%) patients
had hydronephrosis. In the preoperative period, the mean
serum blood urea nitrogen value was 62.88 ± 41.97 mg/dL
and the mean serum creatinine level was 3.21 ± 6.17 mg/
dL. In the postoperative period, these values were 44.4 ±
29.9 mg/dL and 1.91 ± 1.63 mg/dL, respectively. When the
preoperative and postoperative serum urea and creatinine
levels were compared, they were found to be lower in the
postoperative period. However, there was no statistically
significant difference (P > 0.05).
In all patients, standard monitoring (pulse oximetry,
noninvasive blood pressure, electrocardiogram) was
performed. Spinal anesthesia was administered to
42 (91%) of 47 patients who underwent cesarean

Table 1. Demographic data of patients.
Mean age (years)

30 ± 5.34

Time between transplantation and pregnancy (months)

95.34 ± 55.02

Immunosuppressive therapy
Azathioprine + tacrolimus + prednisolone
Cyclosporine + tacrolimus + prednisolone
Tacrolimus
Azathioprine + prednisolone
Cyclosporine + prednisolone

22
14
5
2
4
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Table 2. Obstetrical data of patients.

Table 3. Pregnancy-related diseases of patients.
Number of patients (%)

Number of patients (%)
Gestational week
≥36 weeks
<36 weeks

36.57 ± 1.59 (min 33–max 39)
37 (78.7%)
10 (21.3%)

Number of gravidity
1
2
3
4
6
7

2.47 ± 1.53 (min 1–max 7)
15 (31.9%)
13 (27.7%)
10 (21.3%)
5 (10.6%)
3 (6.4%)
1 (2.1%)

Parity
0
1
2

0.51 ± 0.658 (min 0–max 2)
27 (57.4%)
16 (34%)
4 (8.5%)

Spontaneous abortion
1
2
3

21 (44.7%)
14 (29.7%)
4 (8.5%)
3 (6.5%)

Cesarean indication*
Maternal indication
Fetal indication

41 (87.2%)
6 (12.8%)

*Maternal indications included maternal choice, worsening of
maternal conditions, unfavorable pelvis, and cephalic-pelvic
disproportion. Fetal indications included acute fetal distress.

section. While only 3 (0.6%) patients received general
anesthesia, 2 patients were given general anesthesia due
to inadequate spinal anesthesia. One patient refused
regional anesthesia. The amount of crystalloids given to
the patients in the intraoperative period was 1542.8 ±
535.3 mL. It was determined that only 3 patients received
colloid replacement. The intraoperative urine output
of the patients was approximately 142.0 ± 42.8 mL. The
mean operative time was 61.7 ± 14 min and the mean
duration of anesthesia was 78.1 ± 14.2 min. Thiopental and
rocuronium were used for induction and sevoflurane, and
air was used for maintenance in the patients that received
general anesthesia. A total of 9 (19%) patients underwent
bilateral tubal ligation upon their own request.
The mean weight of the newborns was determined as
2707.3 ± 501.5 g. While the number of newborns with a low
birth weight (<2500 g) was 18 (38%), only 3 (0.6%) among
them were below 2000 g. The mean 1-min Apgar score of
the newborns was 7.54 ± 1.70 while the 5-min Apgar score
was 8.81 ± 1.63. While the number of newborns with a
1-min Apgar score of ≤7 was 17 (36.2%), the number of
those with a 5-min Apgar score of ≤7 was 7 (14.8%). It
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History of chronic hypertension

12 (25.5%)

Gestational hypertension

10 (21.3%)

Presence of concomitant disease
Hydronephrosis
Diabetes mellitus
Hypothyroidism
Hyperthyroidism
Heart disease

10 (21.3%)
4
3
1
1
1

Preeclampsia development

6 (12%)

was found that 36.2% (n = 17) of the newborns required
intensive care. None of the newborns had congenital
malformation.
4. Discussion
It has been reported that the rate of pregnancy is 1.5% in
women with chronic renal failure who receive long-term
dialysis treatment, and the chance of the conception of
a woman in reproductive age after transplantation has
increased to 5% thanks to the development of the treatment
options [1]. In patients with renal transplantation,
planning should be done well before pregnancy, and it is
recommended to wait about 2 years after transplantation
and have minimal or no proteinuria, a serum creatinine
level of <180 mol/L or 2 mg/dL, controlled hypertension if
present, and no pelvicalyceal distention [2,3].
The preoperative examination of the patients is very
important for selecting the best anesthetic technique
for cesarean section in pregnant women with renal
transplantation. It should be focused on concomitant
problems and renal functions in the patients, and should
be optimized in this respect.
The American Society of Transplantation recommends
that pregnancy should be planned at least 1 year after
transplantation in order to obtain the stability of the graft
organ [4]. It is stated that this period may be up to 2 years
due to the risk of rejection in renal transplant patients [5].
This is necessary to optimize immunosuppressive therapy
and to adjust the low dose during pregnancy. Davison [6]
examined 1569 pregnancies in 1009 women after renal
transplantation, and pregnancy was terminated in 22%
of the pregnant women. The rate of spontaneous abortion
was 16% and the rate of perinatal mortality was 8%. In
all of our patients, the time between transplantation and
pregnancy was above 2 years. However, it was found that
19 patients (40%) had more than 3 pregnancies, and most
of those previous pregnancies resulted in spontaneous
abortion.
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Immunosuppressive therapy is necessary for both
graft preservation and the prevention of rejection during
pregnancy. Gestational diabetes and hypertension are
very common in transplantation patients receiving
corticosteroid therapy. Patients using glucocorticoids
may develop Cushing’s syndrome, and it should be kept
in mind that airway management may be challenging [6].
During our study, there were no data suggesting that our
patients who were given general anesthesia had difficult
intubation. It is necessary to pay attention to the maternal
blood pressure, the blood glucose, and the creatinine and
electrolytes (potassium, magnesium etc.) in patients who
are using calcineurin inhibitors (cyclosporine, tacrolimus)
[7]. Interactions of these drugs with anesthetic drugs are
also important. For example, as a result of azathioprine
use, bone marrow suppression may occur and cause
leukopenia or thrombocytopenia [8–11]. The other side
effects of azathioprine include gastrointestinal intolerance,
liver function abnormalities, and infections. Cyclosporine
or tacrolimus may cause reduced gastric emptying
and they should be given 4 h preoperatively because of
this side effect. The other side effect of cyclosporine is
neurotoxicity. Thorough neurological examination is
important in patients using cyclosporine as it contributes
to seizures, paresthesia, and tremors. Paresthesia is very
important if regional anesthesia is preferred. Tacrolimus
may interact with many drugs due to its long half-life (57–
63 h). In particular, its use with calcineurin inhibitors may
potentiate nephrotoxicity [12]. In addition, cremophor,
the metabolite of cyclosporine, potentiates the effects of
neuromuscular agents [13]. Because of all these reasons,
careful examination of the drugs used before anesthesia
becomes very important when choosing an anesthetic
technique.
A history of chronic hypertension is common in
patients with renal transplantation. While the rate of
hypertension is 53%–68%, this is mostly due to the
hypertensive effect of existing diseases or calcineurin
inhibitors before pregnancy [14]. Aggravation of
hypertension during pregnancy increases the risk of
preeclampsia. While the incidences of preeclampsia
during pregnancy vary between 27% and 38%, it has been
reported to occur 4 times more in transplantation patients
compared to healthy pregnant women [15]. Preeclampsia
should be carefully monitored for in renal transplant
recipients because its diagnosis is more difficult in these
patients, most of who have chronic hypertension and
proteinuria [16]. In preeclamptic patients, care should be
taken with regard to complications such as fluid balance,
hemodynamics, coagulation profile, and airway and
pulmonary edema during the preanesthetic assessment.
Among our patients, 12 (25.5%) were hypertensive before
pregnancy while 10 (21.3%) had gestational hypertension
and 6 (12%) had preeclampsia.

Pregnancy does not cause organ rejection by itself and
the transplanted kidney adapts well to the physiological
changes associated with pregnancy [17]. Successful
pregnancies are seen in patients who do not have high
blood pressure or creatinine level, or significant proteinuria
without affected graft functions [18]. Hydronephrosis
may develop as a result of the growth of the uterus and
the compression on the urethra during pregnancy,
leading to complications such as reflux nephropathy
and pyelonephritis. Only 4 of our patients developed
hydronephrosis and none had urinary tract infection.
The first choice in obstetric anesthesia is regional
anesthesia, if there is no contraindication. In pregnant
women with renal transplantation, anesthesia practice is
basically not different from that of other pregnant women,
and the patients’ characteristics and physical conditions
should be taken into consideration in the decision of
general or regional anesthesia [19]. The anesthesia type
should be selected depending on the functional status
of the transplanted kidney, the cardiovascular status, the
hematological status, and the indication for cesarean.
In the absence of impaired renal function, anesthesia
management is similar to that of a healthy pregnant
woman [20,21]. However, although the creatinine levels
of patients are normal, the probability of having low
glomerular filtration rate (GFR) and plasma flow is
high; therefore, the duration of the action of the drugs
excreted renally may be longer. From inhalation agents,
isoflurane, desflurane, and sevoflurane have been shown
to be safe at clinical doses during general anesthesia [22].
Those not excreted renally can be preferred as muscle
relaxants (cisatracurium, mivacurium, and atracurium).
It should be kept in mind that vecuronium causes renal
vasoconstriction. Rocuronium, which is eliminated in the
liver, is a muscle relaxant with moderate potency and is a
good choice for rapid sequence intubations [21]. In our
patients, for general anesthesia, rocuronium was used.
The effect of regional anesthesia on kidney functions
depends on the extent and the level of sympathetic block.
In hypovolemic patients with impaired cardiac functions,
sudden decreases in preload and afterload may decrease
the mean arterial pressure, coronary perfusion pressure,
and renal perfusion pressure. While renal vascular
autoregulation is maintained by regional anesthesia, the
perfusion pressure does not change. GFR changes very
little due to renal vascular resistance. When regional
anesthesia is administered through sensory block of the T6
level, renal blood flow does not change. There are studies
indicating the beneficial effects of ephedrine, which is used
in the treatment of hypotension during cesarean section,
on renal function in major vascular surgeries [23]. Only
8 (17%) of our patients had hypotension, and the mean
amount of ephedrine used in symptomatic treatment
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in addition to fluid replacement was 8.125 mg. Like
hypervolemia, hypovolemia should also be avoided in the
perioperative period, because transplanted kidneys are
very sensitive to hypovolemia [24]. It is thought that this is
due to the transplanted kidney being denervated and not
be able to rapidly adapt to hypotension with hypovolemia
[22]. As a result of this, acute tubular necrosis may arise
in the kidney. Therefore, attention should be paid to
keeping the urine output above 1 mL/kg/h while hydrating
[25]. The amount of crystalloids given to our patients
was approximately 1542.8 ± 535.3 mL, while 4 patients
received colloid replacement. The intraoperative urine
output of the patients was approximately 142.0 ± 42.8
mL. There was not a problem in the urine outputs of the
patients in the postoperative period. Especially in the
postoperative period, the serum urea and creatinine levels
were lower than that of the preoperative period. Although
this difference was not statistically significant, we are of
the opinion that this may be due to the small size of our
sample. In conclusion, spinal anesthesia can be preferred
to general anesthesia in terms of maintenance of renal
functions. In our study, there was not a change between
the pre- and postoperative serum urea and creatinine
levels of the patients that were given general anesthesia.
The rate of preterm birth in pregnant women
with transplantation is around 50%. Preterm labor,
the premature rupture of membranes, and IUGR are

commonly seen in neonates [26]. IUGR has been reported
as 26.9% [2,16]. Thompson et al. [27] indicated that the
reason for these is associated with immunosuppressive
therapy. Oliveira et al. [28] argued that other factors such
as hypertension are also associated with this. While 21.3%
of our patients had preterm delivery, it was found that the
rate of newborns with a weight of 2500 g and below was
38%. The rate of requirement for intensive care was 36.2%.
During pregnancy, renal functions are closely
associated with the condition of the fetus [29]. It has been
stated that immunosuppressive therapy does not cause a
change in the incidence of fetal malformation [30]. None
of the newborns in our study had congenital malformation.
In conclusion, pregnant women with renal
transplantation are a high-risk group from nephrologic,
obstetric, and anesthetic points of view, and maternal
and fetal risks are always present. Before deciding on the
anesthetic technique, the detailed evaluation of the medical
history and physical condition of the mother, as well as
not ignoring the condition of the fetus, will be the best
approach for the obstetric anesthesiologist. However, we
are of the opinion that regional anesthesia is more reliable
in terms of preserving the transplanted kidney in patients
without contraindication. We suggest that this method of
anesthesia has some advantages in terms of maintaining
postoperative renal function and higher Apgar scores in
newborns with low birth weights.
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